SOL-1 expected to be fully randomized by YE 2024 with topline data expected in Q4 2025 Active clinical trial sites now enrolling patients d ...

Robust firmonertinib monotherapy activity in front-line EGFR PACC mutant NSCLC including in patients with brain metastasesTop-line pivotal data ...

But at what cost are we adults avoiding such failures ... citing Keeley’s unrelated drug use. The removal happened shortly ...

The current pain caused by the high cost of the GLP-1 agonist anti-obesity drugs will pass. Prachi Patkee and other analysts ...

Ipsen to present new data on elafibranor at The Liver Meeting® 2024Launch of Iqirvo® (elafibranor)1 on track with ...

Those ever-present TV drug ads showing patients hiking, biking or enjoying a day at the beach could soon have a different ...

Elon Musk's ties to the Trump administration pose potential conflicts of inteterest for his various businesses that have ...

In anticipation of his second term, President-elect Donald Trump has already revived the good ol’ “flood the zone with shit” ...

MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) ("MediPharm", "MediPharm Labs" or the "Company") a pharmaceutical ...

Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, "Eisai") and Biogen Inc. (Nasdaq: BIIB, Corporate headquarters: ...

Those surveyed said issues putting them at risk of homelessness included a loss of income or employment, mental or physical health problems and rising living costs. The Big Issue ... They might have ...

The Global Intent Based Networking Market is projected to grow at a CAGR of 24% from 2024 to 2030, according to a new report published by Verified Market Reports ®. The report reveals that the market ...